bpc-157 safety evidence human trials FDA's Review Of Peptides Signals A Growing Public Health Challenge Repost @peptides with @use.repost ・・・

Kivimki M, Hamer M, Batty GD, Geddes JR, Tabak AG, Pentti J, et al

What the human studies say about DSIP Two older human studies are often

repair, fibrosis, and age-related functional decline Part of broader senolytic/senomorphic research into aging, longevity,

Liver disease, as vitamin B12 metabolism occurs in the liver and may be affected 6

However, at this stage, we do not yet have sufficient high-quality human data to fully understand the safety, efficacy, and long-term effects of BPC-157

We know that for a peptide with such a delicate GHK-Cu half life, starting with anything less than the highest purity is a failed experiment waiting to happen